CBD Science is leading the development of cannabis-based treatments for cancer pain in the UK and Europe.
We are working with world-class physicians to pursue the legal availability of new pain treatments, through our Real World Evidence trials.
Our trials are conducted on cancer patients, in a clinical setting, using our medicinal cannabis products, starting with the UK and expanding to Europe.
RWE trials are conducted on diagnosed cancer patients suffering from chronic pain. Patient level Clinical Evidence is used to assess the value of treatments based on actual health outcomes.
Real-world performance will enable individual management solutions which will lead to the development of safer, more suitable patient pain management programs.
A diverse team with extensive experience in pharmaceuticals, regulation and finance
25+ years of experience with some of Canada’s largest organizations spanning many industries including Oil and Gas, Government, Distribution, Pharmaceutical, and Health Care. An extensive background operational management and technology background.
Mike is the former Deputy Medical Director at NHS England and has wide-ranging experience including planning, commissioning and providing services, leading clinical management teams on a national basis.
20+ years of industry experience designing custom-built manufacturing and processing equipment for world leading manufacturers with customers in over 50 countries around the world. With a focus on ideation and innovation, Rocky uses the latest technologies to successfully take projects from inception to implementation.
Mike’s depth of experience in entrepreneurship, venture capital and government relations is evident by his past leadership of AVAC, Canada’s largest Agri-Tech venture capital fund and acting president of National Research Council.
30+ years in the pharmaceutical industry holding senior management positions in Astra Zenca, GlaxoSmithKline and Bristol Myers before starting B2B companies specializing in Pharma Market Access, his most recent having been sold to IQVIA.
25+ years of public practice and company management advising corporations and their executives on financing, mergers and acquisitions, going public transaction, continuous disclosure obligations, and corporate governance.
Mike is the former Deputy Medical Director at NHS England and has wide-ranging experience including planning, commissioning and providing services, leading clinical management teams on a national basis.
Barney is a product & marketing entrepreneur focussing his efforts to enable access to life changing plant medicines for patients in need. Barney has worked closely with the Conscious Fund, a Venture Capital Fund focused on cannabis & psychedelics.
